Range
2.7 - 2.8
Vol / Avg.
108.8K/3.9M
Div / Yield
-
52 Wk
2.35 - 7
Mkt Cap
35.5M
Payout Ratio
-
Open
2.8
P/E
-
Shares
12.9M
Outstanding
12.9M
Total Float
8.7M
Sector: Health Care.Industry: Biotechnology
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-24
REV
Q2 2021Est.ActualSurprise
EPS0.510
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

TransCode Therapeutics Questions & Anwsers

Q

How do I buy TransCode Therapeutics (RNAZ) stock?

A

You can purchase shares of TransCode Therapeutics (NASDAQ: RNAZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TransCode Therapeutics's (RNAZ) competitors?

Q

What is the target price for TransCode Therapeutics (RNAZ) stock?

A

There is no analysis for TransCode Therapeutics

Q

Current Stock Price for TransCode Therapeutics (RNAZ)?

A

The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $2.75 last updated Mon Oct 25 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does TransCode Therapeutics (RNAZ) pay a dividend?

A

There are no upcoming dividends for TransCode Therapeutics.

Q

When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?

A

TransCode Therapeutics’s $Q3 earnings are confirmed for after-market on $November 24, 2021.

Q

Is TransCode Therapeutics (RNAZ) going to split?

A

There is no upcoming split for TransCode Therapeutics.

Q

What sector and industry does TransCode Therapeutics (RNAZ) operate in?

A

TransCode Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.